Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Nasonex mometasone furoate: Post-marketing study data

July 4, 2005 7:00 AM UTC

Data from a placebo-controlled trial in 299 patients showed that 200 µg once-daily Nasonex for 16 weeks met both the primary and secondary endpoints. Nasal congestion was improved in 74.3% of the pati...